BioTech Mag Search: Biology
Abzena plots 6th biologics plant as demand for mammalian cell-line production continues to grow
7 days ago - By San Diego Biotechnology
With demand for biologics manufacturing at an all-time high, UK CDMO Abzena has rushed to add a bigger footprint to keep up. Now looking to expand its US presence, Abzena will tack on another manufacturing site - its third stateside.
Abzena said the ex......
Read more ...
Search by Tags
Biology Biologic Biological Plants Footprint Manufacturing News Syndication
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Devices and techniques used to obtain and analyse 3‐Dimensional cell cultures
Abstract Cell cultures are indispensable for both basic and applied research. Advancements in cell culture and analysis increase their utility for basic research and...
Unleashing the cancer-fighting gene TP53 in leukemia with a novel...
Unleashing the cancer-fighting gene TP53 in leukemia with a novel combination treatment arlene.weintraub Tue, 01/19/2021 - 08:18
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA ntaylor Tue, 01/19/2021 - 08:16
Lilly gives $60M to Merus, ties in $1.6B in biobucks for next-gen cancer...
Lilly gives $60M to Merus, ties in $1.6B in biobucks for next-gen cancer research pact badams Tue, 01/19/2021 - 07:44
As coronavirus variants trigger new alarms, the NIH is putting an...
Over the past year, the world has been transfixed by the development of new vaccines to fight SARS-CoV-2. In a frenzy of activity, the new mRNA approach has delivered...
CannabisGDB：a comprehensive genomic database for Cannabis Sativa L
Abstract Being one of the world's oldest crops with significant economic and medicinal importance, Cannabis Sativa L. has attracted an enormous amount of attention and become...
Biohaven flunks Alzheimer's phase 2/3, touts failed subgroup as sign of efficacy
Biohaven flunks Alzheimer's phase 2/3, touts failed subgroup as sign of efficacy ntaylor Tue, 01/19/2021 - 06:20
Novartis Gene Therapies: Associate Director, Process Science -Gene Therapy
Novartis Gene Therapies: Overview Ready to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological...
STED lithography in microfluidics for 3D thrombocyte aggregation testing
Three-dimensional photopolymerization techniques such as multiphoton polymerization lithography and stimulated emission depletion lithography are powerful tools for fabricating...
MethylationToActivity: a deep-learning framework that reveals promoter...
Although genome-wide DNA methylomes have demonstrated their clinical value as reliable biomarkers for tumor detection, subtyping, and classification, their direct biological...